<!-- dedup-label: TTFields/Optune Lua canonical: STELLAR final, HDE-only regulatory, TIGER registry, May 2026 upd
|title=TTFields / Optune Lua for Mesothelioma: STELLAR Trial, FDA HDE Approval & 2026 Treatment Guide
...
73 KB (9,572 words) - 17:52, 20 May 2026
* '''Tumor Treating Fields Approved:''' May 2019 (Optune Lua)
| style="padding:10px; " | '''FDA approves Tumor Treating Fields (Optune Lua)'''
...
20 KB (2,497 words) - 23:25, 14 May 2026
| style="padding:10px;" | TTFields (Optune Lua)
...
14 KB (1,840 words) - 23:25, 14 May 2026
=== Tumor Treating Fields (TTFields / Optune Lua) ===
...t 150 kHz to disrupt cancer cell division. The NovoTTF-100L device (Optune Lua) was approved via Humanitarian Device Exemption in May 2019 based on the ST
...
55 KB (6,928 words) - 23:25, 14 May 2026
* '''Tumor Treating Fields:''' Optune Lua device approved 2019
* Optune Lua device
...
28 KB (3,459 words) - 13:51, 23 May 2026
| style="padding:10px;" | FDA approval of Optune Lua
* '''Tumor Treating Fields:''' Optune Lua with chemotherapy (approved May 2019)
...
38 KB (4,762 words) - 23:25, 14 May 2026
=== TTFields/Optune Lua ===
TTFields (tumor treating fields), delivered via the Optune Lua device (Novocure), received FDA Humanitarian Device Exemption (HDE) approva
...
111 KB (14,507 words) - 23:25, 14 May 2026
* [[TTFields Optune Lua]]
...
28 KB (3,537 words) - 23:25, 14 May 2026
...der-bottom:1px solid #dee2e6;" | '''[[TTFields_Optune_Lua|TTFields (Optune Lua)]]'''
* [[TTFields_Optune_Lua|TTFields / Optune Lua for Mesothelioma]]
...
67 KB (8,772 words) - 23:06, 14 May 2026
'''Tumor Treating Fields (TTFields):''' The FDA-approved Optune Lua device costs approximately $21,000 per month based on manufacturer pricing.
...
39 KB (4,968 words) - 23:25, 14 May 2026
=== Tumor Treating Fields (TTFields/Optune) ===
...inition:''' Tumor Treating Fields (TTFields), delivered through the Optune Lua device, is a novel treatment that uses low-intensity alternating electric f
...
218 KB (26,785 words) - 23:07, 14 May 2026
'''Tumor Treating Fields (TTFields):''' The Optune Lua device, approved via the FDA's Humanitarian Device Exemption pathway, deliv
* Tumor Treating Fields (TTFields/Optune Lua) combined with chemotherapy achieved median OS of 18.2 months in the single
...
97 KB (12,342 words) - 13:51, 23 May 2026
...herapy]], [[CAR-T Cell Therapy|CAR-T cell therapy]], and [[TTFields Optune Lua|tumor treating fields]] — will require updated protocols for managing novel
...
71 KB (9,119 words) - 23:25, 14 May 2026
* [[TTFields_Optune_Lua|TTFields / Optune Lua for Mesothelioma]]
...
71 KB (9,306 words) - 23:06, 14 May 2026
'''Tumor Treating Fields (TTFields/Optune Lua)''' remains approved only under the Humanitarian Device Exemption pathway (
...
62 KB (7,842 words) - 23:25, 14 May 2026
